<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05062733</url>
  </required_header>
  <id_info>
    <org_study_id>PEC 20-07-001</org_study_id>
    <nct_id>NCT05062733</nct_id>
  </id_info>
  <brief_title>SEBBIN Round, Anatomical and Biconvex Gluteal Implants</brief_title>
  <official_title>Prospective Observational Study About SEBBIN Gluteal Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe SEBBIN</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe SEBBIN</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is part of the clinical evaluation of SEBBIN silicone gel-filled gluteal implants,&#xD;
      included in the technical file of the device. The aim of the study is to gather additional&#xD;
      data about the safety and effectiveness of the device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2033</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>At 10 years of follow-up</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Complication</condition>
  <condition>Prosthesis Durability</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The intended target population for the gluteal Implants is women or men, who desire an&#xD;
        increase in volume of the gluteal region for aesthetic or reconstruction reason.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is a man or a woman ≥ 18 years old at the time of inclusion.&#xD;
&#xD;
          -  The patient is planned for a unilateral or bilateral gluteal implant placement with&#xD;
             SEBBIN implants as per investigator decision&#xD;
&#xD;
          -  The patient has been informed of the study, has read the patient informed consent and&#xD;
             provided consent for the study in writing.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient implanted with silicone implants somewhere else in the body.&#xD;
&#xD;
          -  Patient candidate for implantation with custom-designed implants.&#xD;
&#xD;
          -  Participation in another interventional clinical study (participation into an&#xD;
             observational study is permitted) with a medicinal product or a medical device in the&#xD;
             30 days prior to enrolment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Groupe SEBBIN</name>
      <address>
        <city>Saint-Ouen-l'Aumône</city>
        <zip>95310</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Stéphane Piris, MS</last_name>
      <phone>+33 1 34 42 13 28</phone>
      <email>stephane.piris@sebbin.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

